Delivery Order SPE2DB20D9223-SPE2DB23FV80G

Award Date 12/2/22
Potential Completion Date 12/23/22
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,038.50 award is for the delivery of Mirena 52 mg systems, a specialized contraceptive product, with a period of performance through April 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the supply of Mirena 52 mg Systems to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $1,776.00 firm fixed-price delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring...
This firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $3,552.00 contract is to provide the Mirena 52 mg systems, a contraceptive device, with an ultimate completion date of August 20, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) for the delivery of Mirena 52 mg systems, a specialized contraceptive product. The $30,447.00 firm fixed-price delivery order has an ultimate completion date of October 19, 2021 and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $7,104.00 under the Defense Logistics Agency's (DLA) SPE2DB program. The contract is for the supply of Mirena 52 mg systems, a contraceptive product, to support the recurring medical supply needs of military health facilities. The contract is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,059.60, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to provide Mirena 52 mg systems, a contraceptive device. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $2,960 contract is to provide 4566430788 Mirena 52 mg systems, a specialized contraceptive product, with a period of performance through November 29, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery orders for a...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $3,124.68 for the supply of Mirena 52 mg Systems, a type of intrauterine contraceptive device. The contract is a firm fixed-price agreement with a period of performance through March 18, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $87,144.00 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) for the provision of Mirena 52 mg Systems, a contraceptive medication. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,552.00 firm fixed-price delivery order is for the supply of Mirena 52 mg systems, a contraceptive device. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC...
  • SPE2DB20D9223
    Indefinite Delivery Contract
  • SPE2DB20D9223-SPE2DB23FV80G
    Delivery Order

This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract award, valued at $3,381.18, is for the delivery of Mirena 52 mg systems, a contraceptive device. The contract is a firm fixed-price delivery order with a completion date of December 23, 2022.

DMS Pharmaceutical Group Inc. holds a large Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. This contract award is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 2/27/25, 9:42 AM